ZA882407B - Human somatomedin carrier protein subunits and process for producing them - Google Patents

Human somatomedin carrier protein subunits and process for producing them

Info

Publication number
ZA882407B
ZA882407B ZA882407A ZA882407A ZA882407B ZA 882407 B ZA882407 B ZA 882407B ZA 882407 A ZA882407 A ZA 882407A ZA 882407 A ZA882407 A ZA 882407A ZA 882407 B ZA882407 B ZA 882407B
Authority
ZA
South Africa
Prior art keywords
carrier protein
protein subunits
producing
human
human somatomedin
Prior art date
Application number
ZA882407A
Other languages
English (en)
Inventor
Martin Spencer Emerald
Original Assignee
Biogrowth, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogrowth, Inc. filed Critical Biogrowth, Inc.
Publication of ZA882407B publication Critical patent/ZA882407B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA882407A 1987-04-06 1988-04-07 Human somatomedin carrier protein subunits and process for producing them ZA882407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06

Publications (1)

Publication Number Publication Date
ZA882407B true ZA882407B (en) 1988-09-28

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882407A ZA882407B (en) 1987-04-06 1988-04-07 Human somatomedin carrier protein subunits and process for producing them

Country Status (11)

Country Link
EP (2) EP0308500B1 (fr)
JP (1) JP2648951B2 (fr)
AT (1) ATE90690T1 (fr)
AU (1) AU627423B2 (fr)
CA (1) CA1340295C (fr)
DE (1) DE3881801T2 (fr)
DK (1) DK677688A (fr)
ES (1) ES2058341T3 (fr)
IL (1) IL85983A (fr)
WO (1) WO1988007863A1 (fr)
ZA (1) ZA882407B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
DE3854842T2 (de) * 1988-04-12 1996-06-13 Amgen Boulder Inc Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
CA1341598C (fr) * 1988-07-15 2009-09-29 Central Sydney Area Health Service Sous-unite labile en milieu acide d'un complexe proteique se liant a un factuer de croissance insulinuide
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
RU2126683C1 (ru) * 1992-12-17 1999-02-27 Товарищество с ограниченной ответственностью "САМИ" Способ получения антисоматотропной сыворотки
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US20030069177A1 (en) 2000-05-16 2003-04-10 Genentech, Inc. Method for treating cartilage disorders
DE60042550D1 (de) 1999-01-06 2009-08-27 Genentech Inc Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
CA2356109C (fr) 1999-01-06 2008-04-22 Genentech, Inc. Variants mutants du facteur de croissance insulinomimetique (igf) de type i
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
CA2524305C (fr) 2003-05-01 2015-12-08 Imclone Systems Incorporated Anticorps entierement humains diriges contre le recepteur du facteur de croissance 1 de type insuline
DK2274978T3 (en) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
EP1670822A2 (fr) 2003-10-03 2006-06-21 Genentech, Inc. Proteines de liaison a l'igf
KR101246504B1 (ko) 2005-06-17 2013-03-26 임클론 엘엘씨 항－ＰＤＧＦＲα 항체
KR101353706B1 (ko) 2006-02-03 2014-02-18 유니버시티 오브 워싱톤 전립선 암 치료용 보강제로서의 ⅰｇｆ-ⅰｒ 길항제
KR20200097679A (ko) 2017-09-11 2020-08-19 샤이어 휴먼 지네틱 테라피즈 인크. 만성 폐 질환 치료를 위한 방법 및 조성물
ES3005966T3 (en) 2020-10-19 2025-03-17 Oak Hill Bio Ltd Compositions suitable for use in neonates
JP2025502349A (ja) 2022-01-19 2025-01-24 オーク ヒル バイオ リミテッド Ｉｇｆ－１／ｉｇｆｂｐの酸化を低減するための組成物および方法
WO2023242439A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Stabilisation vasculaire (nourrissons prématurés)
WO2023242442A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Procédé de maturation/différenciation de neurones et/ou de modulation du nerf vague
WO2023242440A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Traitement des poumons chez les nourrissons
IL322721A (en) 2023-02-14 2025-10-01 Oak Hill Bio Ltd Treatment of healing dysregulation in digestive tract tissue

Also Published As

Publication number Publication date
EP0308500B1 (fr) 1993-06-16
IL85983A0 (en) 1988-09-30
EP0308500A1 (fr) 1989-03-29
ES2058341T3 (es) 1994-11-01
DE3881801D1 (de) 1993-07-22
CA1340295C (fr) 1998-12-29
DE3881801T2 (de) 1993-12-23
AU627423B2 (en) 1992-08-27
WO1988007863A1 (fr) 1988-10-20
ATE90690T1 (de) 1993-07-15
DK677688D0 (da) 1988-12-05
EP0294021A1 (fr) 1988-12-07
AU1702088A (en) 1988-11-04
JP2648951B2 (ja) 1997-09-03
IL85983A (en) 1994-10-07
JPH01502986A (ja) 1989-10-12
DK677688A (da) 1988-12-05

Similar Documents

Publication Publication Date Title
IL85983A0 (en) Human somatomedin carrier protein subunits and process for producing them
HU895836D0 (en) Process for the preparation of carrier proteins
ZA899832B (en) Human somatomedin carrier protein subunits and process for producing them;recombinant dna molecules,hosts,processes and human somatomedian carrier protein-like polypeptides
AU1527188A (en) Factor viii binding domain of von willebrand factor
HU901326D0 (en) Recombinant protein receptor and process for production thereof
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI953525L (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
EP0562508A3 (en) Protein with bone formation ability and process for its production
HUT55800A (en) Process for producing anticoagulant peptides
AU576508B2 (en) Sythetic peptides antigenically corresponding to brain specific proteinoids
HUT53125A (en) Process for producing peptides with anticoagulant activity
HUT64369A (en) Collagen binding protein and method for producing it
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith